Demyelinating Autoimmune Diseases, CNS  >>  autologous mesenchymal stem cells  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
autologous mesenchymal stem cells / Tianjin Medical University General Hospital
NCT02249676: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Completed
2a
15
RoW
Autologous mesenchymal stem cells, MSC
Tianjin Medical University General Hospital
Devic's Syndrome, Devic's Neuromyelitis Optica, Devic Syndrome, Devic's Disease, Devic Disease
12/14
12/14

Download Options